Related references
Note: Only part of the references are listed.Phase II Study of Weekly Vinblastine in Recurrent or Refractory Pediatric Low-Grade Glioma
Eric Bouffet et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Genetic Aberrations Leading to MAPK Pathway Activation Mediate Oncogene-Induced Senescence in Sporadic Pilocytic Astrocytomas
Karine Jacob et al.
CLINICAL CANCER RESEARCH (2011)
Phase I Trial of Lenalidomide in Pediatric Patients With Recurrent, Refractory, or Progressive Primary CNS Tumors: Pediatric Brain Tumor Consortium Study PBTC-018
Katherine E. Warren et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Survival and long-term health and cognitive outcomes after low-grade glioma
Gregory T. Armstrong et al.
NEURO-ONCOLOGY (2011)
Impact of Chemotherapy on Disseminated Low-Grade Glioma in Children and Adolescents: Report from the HIT-LGG 1996 Trial
Stephan von Hornstein et al.
PEDIATRIC BLOOD & CANCER (2011)
Lack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and Diffuse Brainstem Glioma: A Pediatric Brain Tumor Consortium Study
Sridharan Gururangan et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma
Maura Massimino et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update
Kavita K. Mishra et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Pediatric low-grade gliomas and the need for new options for therapy Why and how?
Ibrahim Qaddoumi et al.
CANCER BIOLOGY & THERAPY (2009)
Late Effects of Conformal Radiation Therapy for Pediatric Patients With Low-Grade Glioma: Prospective Evaluation of Cognitive, Endocrine, and Hearing Deficits
Thomas E. Merchant et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Objective Response of Multiply Recurrent Low-Grade Gliomas to Bevacizumab and Irinotecan
Roger J. Packer et al.
PEDIATRIC BLOOD & CANCER (2009)
Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: A children's oncology group study
Julia L. Glade Bender et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas
Justin S. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Outcome analysis of childhood low-grade astrocytomas
Paul G. Fisher et al.
PEDIATRIC BLOOD & CANCER (2008)
Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program
Paola Dalla Via et al.
NEURO-ONCOLOGY (2007)
Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors - A report from the children's oncology group
H. Stacy Nicholson et al.
CANCER (2007)
Temozolomide in children with progressive low-grade glioma
Sridharan Gururangan et al.
NEURO-ONCOLOGY (2007)
The role of telomere maintenance in the spontaneous growth arrest of pediatric low-grade gliomas
Uri Tabori et al.
NEOPLASIA (2006)
Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas: Evidence of diminished cognitive and adaptive functioning in national collaborative research studies (CCG 9891/POG 9130)
DW Beebe et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Survival and functional outcome of children with hypothalamic/chiasmatic tumors
M Fouladi et al.
CANCER (2003)
Share Paper
